The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CTEP #8850: A phase I trial of riluzole and sorafenib in patients with advanced solid tumors.
 
Kristen Renee Spencer
No Relationships to Disclose
 
Janice M. Mehnert
Consulting or Advisory Role - Amgen/Dompé (Inst)
Research Funding - Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); polynoma (Inst); Sanofi (Inst)
Other Relationship - Amgen
 
Antoinette R. Tan
Research Funding - Abbvie (Inst); Bayer/Onyx (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Merck (Inst); Nektar (Inst)
 
Rebecca Anne Moss
Honoraria - Ipsen
Consulting or Advisory Role - Taiho Pharmaceutical
Travel, Accommodations, Expenses - Ipsen; Taiho Pharmaceutical
 
Kelly Levinson
No Relationships to Disclose
 
Mark N. Stein
No Relationships to Disclose
 
Lien Huzzy
No Relationships to Disclose
 
Michael P. Kane
No Relationships to Disclose
 
Darlene Gibbon
No Relationships to Disclose
 
John Joseph Wright
No Relationships to Disclose
 
Joseph Aisner
No Relationships to Disclose
 
Robert S. DiPaola
No Relationships to Disclose
 
Suzie Chen
No Relationships to Disclose
 
Yvonne Wen
No Relationships to Disclose
 
James Goydos
No Relationships to Disclose